Skip to main content
Equibles

BANK OF AMERICA CORP /DE/

Bank

Position in LLY — ELI LILLY & Co

CIK 70858 CHARLOTTE, NC
Back to LLY Full portfolio

Position in LLY

as of Mar 31, 2026 · filed May 18, 2026
Position Value
$10,233,206,495
-$1,701,745,775 QoQ
Shares Held
11,125,832
+0.2% QoQ
Ownership
1.18%
of shares outstanding
% of Portfolio
1.29%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 18.59726086103044.ToString("F0")% Shared 0.ToString("F0")% None 81.40273913896957.ToString("F0")%

Common Shares in LLY Over Time

Shares Held

Position Value (USD)

Derivatives in LLY

reported options exposure · as of Sep 30, 2025
CallValue
$178,160,500
CallShares
233,500
PutValue
$356,855,100
PutShares
467,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

BANK OF AMERICA CORP /DE/ holds $38,990,456,692 across 16 Drug Manufacturers - General names. LLY ranks #1 (26.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
This page 		11,125,832 $10,233,206,495
2 JNJ
Johnson & Johnson
 25,516,697 $6,237,301,411
3 ABBV
AbbVie Inc.
 23,936,943 $5,206,045,728
4 AZN
Astrazeneca PLC
 19,058,327 $3,758,683,247
5 MRK
Merck & Co., Inc.
 30,774,221 $3,701,831,041
6 GILD
Gilead Sciences, Inc.
 19,978,936 $2,784,464,307
7 BMY
Bristol Myers Squibb Co
 32,586,981 $1,976,400,394
8 AMGN
Amgen Inc
 5,121,028 $1,801,833,698

All Filings in LLY

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $10,233,206,495 11,125,832
2025-12-31 $11,934,952,270 11,105,586
2025-09-30 $356,855,100 467,700
2025-09-30 $8,745,158,072 11,461,544
2025-09-30 $178,160,500 233,500
2025-06-30 $313,371,060 402,000
2025-06-30 $8,779,975,788 11,263,166
2025-06-30 $405,745,365 520,500
2025-03-31 $9,095,594,034 11,012,815
2025-03-31 $366,373,676 443,600
2025-03-31 $430,299,110 521,000
2024-12-31 $7,728,972,184 10,011,622
2024-12-31 $272,747,600 353,300
2024-12-31 $247,117,200 320,100
2024-09-30 $9,001,989,382 10,160,947
2024-09-30 $257,719,946 290,900
2024-09-30 $230,521,588 260,200
2024-06-30 $9,762,641,916 10,782,922
2024-06-30 $182,162,456 201,200
2024-06-30 $163,149,476 180,200
2024-03-31 $168,583,932 216,700
2024-03-31 $175,585,572 225,700
2024-03-31 $8,222,887,051 10,569,807
2023-12-31 $203,613,956 349,300
2023-12-31 $76,071,060 130,500
2023-12-31 $5,761,346,359 9,883,597
2023-09-30 $199,221,517 370,900
2023-09-30 $214,583,435 399,500
2023-09-30 $5,284,260,766 9,837,955
2023-06-30 $205,647,730 438,500
2023-06-30 $107,724,706 229,700
2023-06-30 $4,789,419,320 10,212,417
2023-03-31 $89,083,148 259,400
2023-03-31 $142,347,590 414,500
2023-03-31 $3,289,808,370 9,579,548
2022-12-31 $3,463,434,348 9,467,074
2022-12-31 $127,458,656 348,400
2022-12-31 $39,839,976 108,900
2022-09-30 $30,912,260 95,600
2022-09-30 $3,039,433,087 9,399,824
2022-09-30 $40,580,425 125,500
2022-06-30 $84,397,069 260,300
2022-06-30 $3,163,520,536 9,757,026
2022-06-30 $135,528,140 418,000
2022-03-31 $2,658,327,174 9,282,841
2022-03-31 $83,849,136 292,800
2022-03-31 $103,980,947 363,100
2021-12-31 $40,493,852 146,600
2021-12-31 $40,852,938 147,900
2021-12-31 $2,620,634,760 9,487,491

Report a Problem

Category
Description
Email (optional, for follow-up)